Overview

Can Atorvastatin Improve Vascular Function in Women With a History of Preeclampsia?

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of the study is to test the hypothesis that a short course of atorvastatin can improve vascular function in women with a history of preeclampsia, compared to placebo.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Oxford
Treatments:
Atorvastatin
Atorvastatin Calcium
Criteria
Inclusion Criteria:

- Participant is willing and able to give informed consent for participation in the
study.

- Diagnosed with preeclampsia during index pregnancy: defined as (1) new onset
hypertension (>140/90 mmHg) after 20 weeks gestation and (2) proteinuria (>0.3g
protein/24 hours).

- Participants of child bearing potential must be willing to ensure that they or their
partner use effective contraception during the study and for 4 weeks after.

- Participants must be willing to undertake urine pregnancy test at the start of each 4
week phase of the study to exclude unintended pregnancy.

- Participants must have clinically acceptable laboratory markers of renal, thyroid and
hepatic function at enrolment.

- Able (in the Investigator's opinion) and willing to comply with all study
requirements.

- Willing to allow her General Practitioner and consultant, if appropriate, to be
notified of participation in the study and results of clinical laboratory tests.

Exclusion Criteria:

Participants must not be

- Pregnant, lactating during the course of the study.

- Planning pregnancy during course of study or in 4 weeks after study completion

- Taking other medication, whether prescribed or over-the-counter, in the four weeks
before first study dose and during the study other than for example mild analgesia or
hormonal contraception.

- Taking vitamin medications that may interact with atorvastatin (e.g. niacin, Vitamin
D)

- Terminally ill or is inappropriate for placebo medication

- Planning to undertake donation of blood during the study.